RethinkPeptides
ArticlesTopicsResearch

Liraglutide

3 articles in this topic.

Complete Guides

LiraglutideGuide

Liraglutide for Adolescent Obesity: The Pediatric Evidence

FDA-approved liraglutide reduced BMI by 4.6% more than placebo in obese adolescents. Review of all pediatric trials, safety data, and who responds best.

18 min read|Mar 20, 2026

All Articles

Liraglutide

Liraglutide vs Semaglutide Compared

STEP 8 trial: semaglutide produced 15.8% weight loss vs 6.4% for liraglutide. Head-to-head comparison of efficacy, dosing, cost, and cardiovascular data.

11 min read|Mar 22, 2026
Liraglutide

Liraglutide Long-Term Safety Data

What the LEADER trial and 10+ years of real-world data show about liraglutide's cardiovascular benefits, thyroid cancer signal, pancreatitis risk, and GI side effects.

12 min read|Mar 22, 2026

RethinkPeptides

Evidence-based peptide education. No hype, no sales. Just science.

Navigate

All ArticlesTopicsResearch DatabaseEvidence MethodologyDownload DataSearch

About

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of Use

Disclaimer

Content on RethinkPeptides is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Peptides discussed here may not be approved for human use in your jurisdiction.

© 2026 RethinkPeptides. All rights reserved.